We are live on ! Find out more
LCM

LionEye Capital Management Portfolio holdings

AUM $57.4M
1-Year Est. Return 28.02%
This Fund
S&P 500
This Quarter Est. Return
-16.46%
1 Year Est. Return
-28.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.41B
AUM Growth
-$164M
Cap. Flow
+$167M
Cap. Flow %
6.92%
Top 10 Hldgs %
76.96%
Holding
57
New
13
Increased
20
Reduced
4
Closed
17

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.84%
2 Industrials 12.03%
3 Communication Services 5.03%
4 Technology 2.32%
5 Energy 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBD
51
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
-240,000
Closed -$8.4M
HZNP
52
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-200,000
Closed -$6.95M
HZNP
53
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-1,381,000
Closed -$48M
RJET
54
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
-2,058,000
Closed -$18.9M
BRCM
55
DELISTED
BROADCOM CORP CL-A
BRCM
-300,000
Closed -$15.4M
PVA
56
DELISTED
PENN VIRGINIA CORP
PVA
-1,000,000
Closed -$4.38M
MWV
57
DELISTED
MEADWESTVACO CORP
MWV
-520,304
Closed -$24.6M

Similar funds

LionEye Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, LionEye Capital Management held 57 positions worth $2.41B, down 6.4% from $2.58B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

LionEye Capital Management deployed $167M of net new capital in Q3 2015, opening 13 new positions and adding to 20 existing holdings. Its largest new stake was iShares Biotechnology ETF: 270,000 shares worth $27.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Staples Inc, an estimated $24.6M trimmed.

  • LionEye Capital Management's largest Q3 2015 buy was iShares Biotechnology ETF: 270,000 shares worth $27.3M.
  • LionEye Capital Management added most to Houghton Mifflin Harcourt Company in Q3 2015, an estimated $62.3M increase.
  • LionEye Capital Management's biggest Q3 2015 reduction was Staples Inc, cutting an estimated $24.6M.
  • LionEye Capital Management fully exited Teva Pharmaceuticals in Q3 2015, selling an estimated $65M.
  • LionEye Capital Management's ten largest holdings make up 77% of its $2.41B portfolio in Q3 2015.
  • LionEye Capital Management opened 13 new positions and closed 17 in Q3 2015.
  • LionEye Capital Management's portfolio value fell 6.4% quarter-over-quarter to $2.41B.

Based on LionEye Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.